Cargando…
MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary
BACKGROUND: MicroRNAs (miRNA) are 20∼25 nucleotide non-coding RNAs that inhibit the translation of targeted mRNA, and they have been implicated in the development of human malignancies. High grade serous ovarian carcinomas, the most common and lethal subtype of ovarian cancer, can occur sporadically...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749450/ https://www.ncbi.nlm.nih.gov/pubmed/19798417 http://dx.doi.org/10.1371/journal.pone.0007314 |
_version_ | 1782172180586430464 |
---|---|
author | Lee, Cheng-Han Subramanian, Subbaya Beck, Andrew H. Espinosa, Inigo Senz, Janine Zhu, Shirley X. Huntsman, David van de Rijn, Matt Gilks, C. Blake |
author_facet | Lee, Cheng-Han Subramanian, Subbaya Beck, Andrew H. Espinosa, Inigo Senz, Janine Zhu, Shirley X. Huntsman, David van de Rijn, Matt Gilks, C. Blake |
author_sort | Lee, Cheng-Han |
collection | PubMed |
description | BACKGROUND: MicroRNAs (miRNA) are 20∼25 nucleotide non-coding RNAs that inhibit the translation of targeted mRNA, and they have been implicated in the development of human malignancies. High grade serous ovarian carcinomas, the most common and lethal subtype of ovarian cancer, can occur sporadically or in the setting of BRCA1/2 syndromes. Little is known regarding the miRNA expression profiles of high grade serous carcinoma in relation to BRCA1/2 status, and compared to normal tubal epithelium, the putative tissue of origin for high grade serous carcinomas. METHODOLOGY/PRINCIPAL FINDINGS: Global miRNA expression profiling was performed on a series of 33 high grade serous carcinomas, characterized with respect to BRCA1/2 status (mutation, epigenetic silencing with loss of expression or normal), and with clinical follow-up, together with 2 low grade serous carcinomas, 2 serous borderline tumors, and 3 normal fallopian tube samples, using miRNA microarrays (328 human miRNA). Unsupervised hierarchical clustering based on miRNA expression profiles showed no clear separation between the groups of carcinomas with different BRCA1/2 status. There were relatively few miRNAs that were differentially expressed between the genotypic subgroups. Comparison of 33 high grade serous carcinomas to 3 normal fallopian tube samples identified several dysregulated miRNAs (false discovery rate <5%), including miR-422b and miR-34c. Quantitative RT-PCR analysis performed on selected miRNAs confirmed the pattern of differential expression shown by microarray analysis. Prognostically, lower level miR-422b and miR-34c in high grade serous carcinomas were both associated with decreased disease-specific survival by Kaplan-Meier analysis (p<0.05). CONCLUSIONS/SIGNIFICANCE: High grade serous ovarian carcinomas with and without BRCA1/2 abnormalities demonstrate very similar miRNA expression profiles. High grade serous carcinomas as a group exhibit significant miRNA dysregulation in comparison to tubal epithelium and the levels of miR-34c and miR-422b appear to be prognostically important. |
format | Text |
id | pubmed-2749450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-27494502009-10-02 MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary Lee, Cheng-Han Subramanian, Subbaya Beck, Andrew H. Espinosa, Inigo Senz, Janine Zhu, Shirley X. Huntsman, David van de Rijn, Matt Gilks, C. Blake PLoS One Research Article BACKGROUND: MicroRNAs (miRNA) are 20∼25 nucleotide non-coding RNAs that inhibit the translation of targeted mRNA, and they have been implicated in the development of human malignancies. High grade serous ovarian carcinomas, the most common and lethal subtype of ovarian cancer, can occur sporadically or in the setting of BRCA1/2 syndromes. Little is known regarding the miRNA expression profiles of high grade serous carcinoma in relation to BRCA1/2 status, and compared to normal tubal epithelium, the putative tissue of origin for high grade serous carcinomas. METHODOLOGY/PRINCIPAL FINDINGS: Global miRNA expression profiling was performed on a series of 33 high grade serous carcinomas, characterized with respect to BRCA1/2 status (mutation, epigenetic silencing with loss of expression or normal), and with clinical follow-up, together with 2 low grade serous carcinomas, 2 serous borderline tumors, and 3 normal fallopian tube samples, using miRNA microarrays (328 human miRNA). Unsupervised hierarchical clustering based on miRNA expression profiles showed no clear separation between the groups of carcinomas with different BRCA1/2 status. There were relatively few miRNAs that were differentially expressed between the genotypic subgroups. Comparison of 33 high grade serous carcinomas to 3 normal fallopian tube samples identified several dysregulated miRNAs (false discovery rate <5%), including miR-422b and miR-34c. Quantitative RT-PCR analysis performed on selected miRNAs confirmed the pattern of differential expression shown by microarray analysis. Prognostically, lower level miR-422b and miR-34c in high grade serous carcinomas were both associated with decreased disease-specific survival by Kaplan-Meier analysis (p<0.05). CONCLUSIONS/SIGNIFICANCE: High grade serous ovarian carcinomas with and without BRCA1/2 abnormalities demonstrate very similar miRNA expression profiles. High grade serous carcinomas as a group exhibit significant miRNA dysregulation in comparison to tubal epithelium and the levels of miR-34c and miR-422b appear to be prognostically important. Public Library of Science 2009-10-02 /pmc/articles/PMC2749450/ /pubmed/19798417 http://dx.doi.org/10.1371/journal.pone.0007314 Text en Lee et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Lee, Cheng-Han Subramanian, Subbaya Beck, Andrew H. Espinosa, Inigo Senz, Janine Zhu, Shirley X. Huntsman, David van de Rijn, Matt Gilks, C. Blake MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary |
title | MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary |
title_full | MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary |
title_fullStr | MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary |
title_full_unstemmed | MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary |
title_short | MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary |
title_sort | microrna profiling of brca1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2749450/ https://www.ncbi.nlm.nih.gov/pubmed/19798417 http://dx.doi.org/10.1371/journal.pone.0007314 |
work_keys_str_mv | AT leechenghan micrornaprofilingofbrca12mutationcarryingandnonmutationcarryinghighgradeserouscarcinomasofovary AT subramaniansubbaya micrornaprofilingofbrca12mutationcarryingandnonmutationcarryinghighgradeserouscarcinomasofovary AT beckandrewh micrornaprofilingofbrca12mutationcarryingandnonmutationcarryinghighgradeserouscarcinomasofovary AT espinosainigo micrornaprofilingofbrca12mutationcarryingandnonmutationcarryinghighgradeserouscarcinomasofovary AT senzjanine micrornaprofilingofbrca12mutationcarryingandnonmutationcarryinghighgradeserouscarcinomasofovary AT zhushirleyx micrornaprofilingofbrca12mutationcarryingandnonmutationcarryinghighgradeserouscarcinomasofovary AT huntsmandavid micrornaprofilingofbrca12mutationcarryingandnonmutationcarryinghighgradeserouscarcinomasofovary AT vanderijnmatt micrornaprofilingofbrca12mutationcarryingandnonmutationcarryinghighgradeserouscarcinomasofovary AT gilkscblake micrornaprofilingofbrca12mutationcarryingandnonmutationcarryinghighgradeserouscarcinomasofovary |